Explore more publications!
Iceland Entertainment Insider
Got News to Share?

Press Releases

The OpenHW Foundation unveils the first industry-ready RISC-V ecosystem to advance European digital sovereignty
Jan. 26, 2026

The OpenHW Foundation unveils the first industry-ready RISC-V ecosystem to advance European digital sovereignty

Indeterminate GlobeNewswire, Inc.
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
Dec. 22, 2025

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Indeterminate GlobeNewswire, Inc.
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
Jan. 8, 2026

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Russia Dispatches Warships into North Atlantic
Jan. 7, 2026

Russia Dispatches Warships into North Atlantic

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Casa Noosh x Amarna Gallery Present: The Gilded Affair at The Moore Club
Dec. 2, 2025

Casa Noosh x Amarna Gallery Present: The Gilded Affair at The Moore Club

Neutral EIN Presswire
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
Jan. 6, 2026

Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis

Indeterminate GlobeNewswire, Inc.
Contoured Bottles and Containers Market Research Report 2026-35
Jan. 23, 2026

Contoured Bottles and Containers Market Research Report 2026-35

Indeterminate GlobeNewswire, Inc.
Baboo Travel Highlights Sustainable AstroTourism Itineraries Ahead of 2026 Celestial Events
Jan. 22, 2026

Baboo Travel Highlights Sustainable AstroTourism Itineraries Ahead of 2026 Celestial Events

Neutral EIN Presswire
TTW Unveils Top 50 Airports in Europe for 2026
Jan. 22, 2026

TTW Unveils Top 50 Airports in Europe for 2026

Neutral EIN Presswire
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
Nov. 24, 2025

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

Indeterminate GlobeNewswire, Inc.
NATO chief vows to block Russian, Chinese access to Greenland
Jan. 22, 2026

NATO chief vows to block Russian, Chinese access to Greenland

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Residential Remodelers Market: Size, Share, Competitive Overview, and Trend Analysis Report
Jan. 21, 2026

Residential Remodelers Market: Size, Share, Competitive Overview, and Trend Analysis Report

Neutral EIN Presswire
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
Nov. 20, 2025

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

Indeterminate GlobeNewswire, Inc.
Q3 2025 Financial Results
Nov. 14, 2025

Q3 2025 Financial Results

Indeterminate GlobeNewswire, Inc.
TTW Reveals the Top 50 Adventure Travel Destinations of the World for 2026
Dec. 27, 2025

TTW Reveals the Top 50 Adventure Travel Destinations of the World for 2026

Neutral EIN Presswire
Global phenomenon Melanie Wentzel selected as Top Healthcare Strategist by IAOTP
Jan. 14, 2026

Global phenomenon Melanie Wentzel selected as Top Healthcare Strategist by IAOTP

Neutral EIN Presswire
Notice of Results and Investor Presentation 
Nov. 7, 2025

Notice of Results and Investor Presentation 

Indeterminate GlobeNewswire, Inc.
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Nov. 6, 2025

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA

Indeterminate GlobeNewswire, Inc.
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
Nov. 4, 2025

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update

Indeterminate GlobeNewswire, Inc.
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Dec. 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions